Transcranial Direct Current Stimulation for Schizophrenia

Imaging Research Center, Sacramento, CA
SchizophreniaTranscranial Direct Current Stimulation - Device
Eligibility
18 - 35
All Sexes
What conditions do you have?
Select

Study Summary

This trial is studying how well transcranial direct current stimulation (tDCS) works in improving higher-order cognition in people with and without schizophrenia.

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
N/A

Study Objectives

3 Primary · 0 Secondary · Reporting Duration: Assessment will begin immediately following stimulation and last for about 1.5 hours.

Hour 5
Behavioral Response (Cognitive Control Task)
Behavioral Response (Language Task)
EEG Correlates of Language and Cognitive Control

Trial Safety

Phase-Based Safety

1 of 3

Side Effects for

tDCS (Active)
2%skin irritation
2%Car accident
This histogram enumerates side effects from a completed 2021 Phase 2 & 3 trial (NCT02483468) in the tDCS (Active) ARM group. Side effects include: skin irritation with 2%, Car accident with 2%.

Trial Design

3 Treatment Groups

Occipital Stimulation
1 of 3
DLPFC Stimulation
1 of 3
Sham Stimulation
1 of 3

Active Control

Experimental Treatment

Non-Treatment Group

120 Total Participants · 3 Treatment Groups

Primary Treatment: Transcranial Direct Current Stimulation · Has Placebo Group · N/A

DLPFC Stimulation
Device
Experimental Group · 1 Intervention: Transcranial Direct Current Stimulation · Intervention Types: Device
Sham Stimulation
Device
ShamComparator Group · 1 Intervention: Transcranial Direct Current Stimulation · Intervention Types: Device
Occipital Stimulation
Device
ActiveComparator Group · 1 Intervention: Transcranial Direct Current Stimulation · Intervention Types: Device
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transcranial Direct Current Stimulation
2014
Completed Phase 3
~1110

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: assessment will begin immediately following stimulation and last for about 1.5 hours.

Who is running the clinical trial?

University of California, DavisLead Sponsor
866 Previous Clinical Trials
5,026,762 Total Patients Enrolled
3 Trials studying Schizophrenia
275 Patients Enrolled for Schizophrenia

Eligibility Criteria

Age 18 - 35 · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have been diagnosed with schizophrenia, schizophreniform or schizoaffective disorder.

Who else is applying?

What state do they live in?
North Carolina100.0%
How old are they?
65+100.0%
What portion of applicants met pre-screening criteria?
Did not meet criteria100.0%

Frequently Asked Questions

What are the eligibility requirements for participating in this trial?

"This clinical trial can accept up to 120 individuals aged between 18 and 35 that have been diagnosed with schizophrenia. To be eligible, they must not plan on altering their medication in the upcoming month, are not using clozapine as an antipsychotic drug, remain stable while being treated either partially or out-patiently, and had no changes in medications during the past month." - Anonymous Online Contributor

Unverified Answer

What is the uppermost participant limit for this clinical trial?

"Confirmed. Clinicaltrials.gov outlines the commencement date of this study on May 22nd 2019, with a recent edit to the trial posted on January 25th 2022. The research is seeking 120 clinical participants from one centre." - Anonymous Online Contributor

Unverified Answer

Is eligibility for this experiment restricted to individuals younger than 55 years old?

"As listed in the study's inclusion criteria, only individuals between 18 and 35 years old are eligible to participate." - Anonymous Online Contributor

Unverified Answer

Are there still opportunities to join this research experiment?

"Per the information accessible on clinicaltrials.gov, this trial is currently recruiting suitable participants. It was originally posted to the website on May 22nd 2019 and last updated on January 25th 2022." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.